Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
20.5%
% of GNOM's 39 holdings also in PBE
28.6%
% of PBE's 28 holdings also in GNOM
Overlap by Weight
Sector Drift (GNOM minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GNOM |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 7.1% | 5.4% | 5.4% |
|
GILEAD SCIENCES INC | 3.4% | 5.3% | 3.4% |
|
VERACYTE INC | 5.5% | 2.9% | 2.9% |
|
ILLUMINA INC | 2.8% | 4.2% | 2.8% |
|
BIOMARIN PHARMACEUTICAL INC | 4.8% | 2.6% | 2.6% |
Position Highlights (Non-Overlapping Exposures)
GNOM Overweight Relative to PBE
 |
BIONTECH SE SPONSORED ADR | 5.1% |
|
CRISPR THERAPEUTICS AG | 4.7% |
|
ALNYLAM PHARMACEUTICALS INC | 4.5% |
|
AGILENT TECHNOLOGIES INC | 4.4% |
|
LEGEND BIOTECH CORPORATION SPONSORED | 4.2% |
 |
GENSCRIPT BIOTECH CORPORATION | 3.8% |
|
ULTRAGENYX PHARMACEUTICAL IN | 3.7% |
|
AVIDITY BIOSCIENCES INC | 3.3% |
|
BEAM THERAPEUTICS, INC. | 3.3% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 3.2% |
GNOM Underweight Relative to PBE
|
AMGEN INC | -5.0% |
|
NEUROCRINE BIOSCIENCES INC | -4.9% |
|
BIOGEN IDEC INC | -4.7% |
|
UNITED THERAPEUTICS CORP | -4.5% |
|
REGENERON PHARMACEUTICALS | -4.4% |
|
PROTAGONIST THERAPEUTICS, INC. | -4.1% |
|
TG THERAPEUTICS INC | -4.0% |
|
CATALYST PHARMACEUTICAL PART | -3.3% |
|
HALOZYME THERAPEUTICS INC | -3.1% |
|
EXELIXIS INC | -3.0% |